NEJM Journal Watch - General Medicine

Possibly, but more than anything, this study reinforces the fact that statin therapy slows progression of atherosclerosis.

A randomized trial showed no benefit for adding thoracentesis to standard therapy.

In a secondary analysis of the ASPREE trial, bleeding was associated with new functional dependency.

In critically ill patients, augmented enteral protein didn't improve survival or shorten hospital stays.

Patients with obesity who lost weight before TKA did not have better outcomes.

Excess risk is small but varies by hormone type and delivery route.

A 14-day monitor detected more atrial fibrillation but did not affect hospitalization rates for stroke or hemorrhage.

Metformin and GLP-1–receptor agonists seem to prevent some asthma exacerbations.

Patients with early-stage breast cancer who have ER-positive tumors and clinically node-negative axilla can forego sentinel lymph node biopsy without negative consequence.

In patients with low-risk MRSA bacteremia, ceftaroline did not offer therapeutic benefits over vancomycin.